Today: 9 June 2026
Reckitt Benckiser share price slips as buyback rolls on and £1.6bn special dividend vote nears
23 January 2026
1 min read

Reckitt Benckiser share price slips as buyback rolls on and £1.6bn special dividend vote nears

London, 08:00 GMT, January 23, 2026 — Regular session

  • Reckitt Benckiser slipped at the London cash open following Thursday’s close
  • A new filing revealed the company continued its share repurchases for another day under its buyback programme
  • Next week’s vote on a one-off dividend and share consolidation has investors locked in.

Reckitt Benckiser Group plc (RKT.L) shares slipped roughly 1.2%, opening at 6,038 pence on Friday, following a close of 6,114 pence the day before.

The shift unfolds as investors approach several key capital-return events, including a shareholder vote next week on a special dividend and a related share consolidation tied to the sale of Reckitt’s Essential Home business.

Reckitt revealed in a regulatory filing on Friday that it repurchased 49,250 shares on Jan. 22, paying a volume-weighted average price of 6,089.71 pence per share. These shares will be held in treasury. Following the transaction, the company’s total voting rights are now 671,720,907.

The purchases fall within a wider £1 billion share buyback plan. Reckitt announced the current tranche will wrap up on or before Jan. 30, with shares held in treasury until then and cancelled once the tranche completes.

What’s catching the eye for many investors is the planned 235 pence special dividend — a one-off payout of about £1.6 billion — alongside a 24-for-25 share consolidation. The reverse split aims to keep the share price roughly steady after the cash is handed out. According to the schedule, shares will trade ex-special dividend on Feb. 2, with payment set for Feb. 20.

Ex-dividend dates often exaggerate price swings. On the ex-date, the stock usually falls by about the dividend amount, at least on the surface, even though the overall value to shareholders stays the same.

Reckitt revealed this week it’s committing $10 million to WaterEquity’s Everspring Fund, stepping up its efforts in water and sanitation financing. CEO Kris Licht stressed that basic water services “remain profoundly underfunded” and “can’t be solved through philanthropy alone.” WaterEquity’s CEO Paul O’Connell described the timing as “a particularly important moment” as the fund expands. reckitt.com

Still, this capital return hinges on shareholder approval and a smooth process ahead. Any hold-up or choppy markets into early February might push the stock to move based on mechanics and positioning instead of actual sales momentum.

Stock Market Today

  • Ross Stores Investment Gains: $1000 from 2014 Now Worth $4,384
    June 9, 2026, 10:24 AM EDT. A $1000 investment in Ross Stores (ROST) made in June 2014 would be worth $4,384 as of June 20, 2024, marking a 338.42% gain excluding dividends. Ross Stores, an off-price apparel retailer operating over 2,100 stores across the U.S., targets middle-income shoppers with goods priced 20%-70% below regular department store prices. The stock's performance outpaces the S&P 500's 180.02% gain and gold's 70.33% return in the same period. Analysts expect further upside due to strong customer demand and Ross's continued store expansion, with 26 new locations opened recently. The company's consistent earnings beats reinforce its market position in the competitive retail sector.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
Qualcomm stock price ticks up as QCOM lines up Feb. 4 earnings — what traders watch next
Previous Story

Qualcomm stock price ticks up as QCOM lines up Feb. 4 earnings — what traders watch next

Shell share price edges higher in London as Nigeria incentives and Argentina shale sale talk hit the tape
Next Story

Shell share price edges higher in London as Nigeria incentives and Argentina shale sale talk hit the tape

Go toTop